 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Foamix Pharmaceuticals Ltd. (FOMX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-09 Sale | 2019-09-11 5:12 pm | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 43,812 | $3.501 | $153,366 | 123,671 (Direct) | View |
| 2019-08-26 Sale | 2019-08-28 4:36 pm | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 7,049 | $3.27 | $23,050 | 37,498 (Direct) | View |
| 2019-07-15 Sale | 2019-07-17 4:40 pm | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 808 | $2.31 | $1,866 | 44,547 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:28 pm | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 639 | $2.35 | $1,502 | 51,969 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:27 pm | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 3,355 | $2.35 | $7,884 | 211,240 (Direct) | View |
| 2019-07-01 Sale | 2019-07-03 4:26 pm | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 951 | $2.35 | $2,235 | 63,524 (Direct) | View |
| 2019-05-16 Sale | 2019-05-20 6:35 pm | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 10,600 | $2.61 | $27,666 | 55,955 (Direct) | View |
| 2019-04-01 Sale | 2019-04-03 4:42 pm | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 2,519 | $3.75 | $9,446 | 52,608 (Direct) | View |
| 2019-04-01 Sale | 2019-04-03 4:40 pm | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 5,096 | $3.75 | $19,110 | 214,595 (Direct) | View |
| 2019-04-01 Sale | 2019-04-03 4:38 pm | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 1,696 | $3.75 | $6,360 | 64,475 (Direct) | View |
| 2019-03-05 Purchase | 2019-03-06 4:07 pm | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 13,440 | $3.76 | $50,534 | 63,440 (Direct) | View |
| 2018-11-26 Purchase | 2018-12-06 06:09 am | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 112,200 | $3.902 | $437,773 | 112,200 (Direct) | View |
| 2018-12-03 Sale | 2018-12-06 06:06 am | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 68 | $4.05 | $275 | 146,409 (Direct) | View |
| 2018-11-19 Sale | 2018-11-20 4:07 pm | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 5,036 | $3.9 | $19,640 | 146,477 (Direct) | View |
| 2018-11-19 Sale | 2018-11-20 4:05 pm | Foamix Pharmaceuticals Ltd. | FOMX | Howard Alvin D VP | 3,375 | $3.9 | $13,163 | 38,414 (Direct) | View |
| 2018-11-08 Sale | 2018-11-13 06:16 am | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain VP | 683 | $4.58 | $3,128 | 33,602 (Direct) | View |
| 2018-11-08 Sale | 2018-11-13 06:13 am | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 2,062 | $4.58 | $9,444 | 151,513 (Direct) | View |
| 2018-10-01 Sale | 2018-10-02 5:22 pm | Foamix Pharmaceuticals Ltd. | FOMX | Howard Alvin D VP | 234 | $5.81 | $1,360 | 41,789 (Direct) | View |
| 2018-10-01 Sale | 2018-10-02 5:20 pm | Foamix Pharmaceuticals Ltd. | FOMX | Elliott Russell P. VP | 142 | $5.81 | $825 | 12,442 (Direct) | View |
| 2018-10-01 Sale | 2018-10-02 5:18 pm | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 601 | $5.81 | $3,492 | 153,575 (Direct) | View |
| 2018-09-04 Sale | 2018-09-06 4:05 pm | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 67 | $5.67 | $380 | 154,176 (Direct) | View |
| 2018-08-08 Sale | 2018-08-09 4:07 pm | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 8,238 | $5.68 | $46,792 | 154,243 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-04 Exercise | 2019-11-05 4:32 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 32,500 | $0.62 | 182,500 (Indirect) | View |
| 2019-11-04 Exercise | 2019-11-05 4:32 pm | 2004-01-01 2019-11-25 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 32,500 | $0.62 | 182,500 (Indirect) | View |
| 2019-10-15 Exercise | 2019-10-17 4:11 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 90,000 | $0.62 | 150,000 (Indirect) | View |
| 2019-10-15 Exercise | 2019-10-17 4:11 pm | 2004-01-01 2019-11-25 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 90,000 | $0.62 | 150,000 (Indirect) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:20 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 673 | $3.07 | 62,851 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:19 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 463 | $3.07 | 51,506 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:18 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 2,256 | $3.07 | 208,984 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-14 2:59 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 60,000 | $0.62 | 122,500 (Indirect) | View |
| 2019-08-13 Exercise | 2019-08-14 2:59 pm | 2004-01-01 2019-11-25 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 60,000 | $0.62 | 122,500 (Indirect) | View |
| 2019-05-16 Option Award | 2019-07-08 4:50 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 28,195 | $0 | 28,195 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:41 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Bruno Anthony D Director | 28,195 | $0 | 69,695 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:36 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 49,412 | $2.66 | 49,412 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:35 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 28,195 | $0 | 55,955 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:34 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 56,391 | $0 | 69,365 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:27 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 49,412 | $2.66 | 49,412 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 6:27 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | BARBARI SHARON SURREY Director | 49,412 | $2.66 | 49,412 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:09 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 40,712 | $0 | 133,091 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:09 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 94,996 | $3.81 | 133,091 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:08 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 32,569 | $0 | 75,997 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:08 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 75,997 | $3.77 | 75,997 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:06 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 30,127 | $0 | 70,297 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:06 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 70,297 | $3.77 | 70,297 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:04 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 73,282 | $0 | 219,691 (Direct) | View |
| 2019-01-01 Option Award | 2019-01-03 4:04 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 170,993 | $3.77 | 219,691 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-04 4:05 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 50,000 | $0 | 100,000 (Direct) | View |
| 2018-12-03 Option Award | 2018-12-04 4:05 pm | N/A 2028-12-03 | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 100,000 | $4.06 | 100,000 (Direct) | View |
| © 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 Wed, 13 Nov 2019 19:57:38 -0600 | SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |